Porter, John B.

The Pathophysiology of Transfusional Iron Overload

Porter, J. B., & Garbowski, M. (2014) · Hematology/Oncology Clinics of North America

Hemoglobinopathies and Related DisordersIron Metabolism and Disorders

Cited by 120

Results of an international round robin for the quantification of serum non-transferrin-bound iron: Need for defining standardization and a clinically relevant isoform

Jacobs, E. M. G., Hendriks, J. C. M., van Tits, B. L. J. H., Evans, P. J., Breuer, W., Liu, D. Y., Jansen, E. H. J. M., Jauhiainen, K., Sturm, B., Porter, J. B., et al. (2005) · Analytical Biochemistry

Iron Metabolism and DisordersClinical Laboratory Practices and Quality Control

Cited by 101

Inflammation and oxidant-stress in -thalassemia patients treated with iron chelators deferasirox (ICL670) or deferoxamine: an ancillary study of the Novartis CICL670A0107 trial

Walter, P. B., Macklin, E. A., Porter, J., Evans, P., Kwiatkowski, J. L., Neufeld, E. J., Coates, T., Giardina, P. J., Vichinsky, E., Olivieri, N., et al. (2008) · Haematologica

Hemoglobinopathies and Related DisordersIron Metabolism and Disorders

Cited by 87

Poor compliance and increased mortality, depression and healthcare costs in patients with congenital adrenal hyperplasia

Jenkins-Jones, S., Parviainen, L., Porter, J., Withe, M., Whitaker, M. J., Holden, S. E., Morgan, C. L., Currie, C. J., & Ross, R. J. M. (2018) · European Journal of Endocrinology

Sexual Differentiation and DisordersAdrenal Hormones and Disorders

Cited by 85

The Environment of the Lipoxygenase Iron Binding Site Explored with Novel Hydroxypyridinone Iron Chelators

Abeysinghe, R. D., Roberts, P. J., Cooper, C. E., MacLean, K. H., Hider, R. C., & Porter, J. B. (1996) · Journal of Biological Chemistry

Metal-Catalyzed Oxygenation MechanismsInflammatory mediators and NSAID effects

Cited by 70

Hepcidin is suppressed by erythropoiesis in hemoglobin E β-thalassemia and β-thalassemia trait

Jones, E., Pasricha, S.-R., Allen, A., Evans, P., Fisher, C. A., Wray, K., Premawardhena, A., Bandara, D., Perera, A., Webster, C., et al. (2015) · Blood

Hemoglobinopathies and Related DisordersIron Metabolism and Disorders

Cited by 68

Iron chelation therapy in thalassemia major: A systematic review with meta-analyses of 1520 patients included on randomized clinical trials

Maggio, A., Filosa, A., Vitrano, A., Aloj, G., Kattamis, A., Ceci, A., Fucharoen, S., Cianciulli, P., Grady, R. W., Prossomariti, L., et al. (2011) · Blood Cells, Molecules, and Diseases

Hemoglobinopathies and Related DisordersIron Metabolism and Disorders

Cited by 65

Absorption and tolerability of taste-masked hydrocortisone granules in neonates, infants and children under 6 years of age with adrenal insufficiency

Neumann, U., Whitaker, M. J., Wiegand, S., Krude, H., Porter, J., Davies, M., Digweed, D., Voet, B., Ross, R. J., & Blankenstein, O. (2018) · Clinical Endocrinology

Adrenal Hormones and DisordersPharmaceutical studies and practices

Cited by 64

Is physiological glucocorticoid replacement important in children?

Porter, J., Blair, J., & Ross, R. J. (2017) · Archives of Disease in Childhood

Adrenal Hormones and DisordersStress Responses and Cortisol

Cited by 50

The efficacy of an iron chelator (CP94) in increasing cellular protoporphyrin IX following intravesical 5-aminolaevulinic acid administration: an in vivo study

Chang, S.-C., MacRobert, A. J., Porter, J. B., & Brown, S. G. (1997) · Journal of Photochemistry and Photobiology B: Biology

Photodynamic Therapy Research StudiesPorphyrin Metabolism and Disorders

Cited by 49

Curcumin Contributes to In Vitro Removal of Non-Transferrin Bound Iron by Deferiprone and Desferrioxamine in Thalassemic Plasma

Srichairatanakool, S., Thephinlap, C., Phisalaphong, C., Porter, J., & Fucharoen, S. (2007) · Medicinal Chemistry

Iron Metabolism and DisordersHemoglobinopathies and Related Disorders

Cited by 46

Efficacy of Curcuminoids in Alleviation of Iron Overload and Lipid Peroxidation in Thalassemic Mice

Thephinlap, C., Phisalaphong, C., Fucharoen, S., Porter, J., & Srichairatanakool, S. (2009) · Medicinal Chemistry

Hemoglobinopathies and Related DisordersIron Metabolism and Disorders

Cited by 32

Immediate-release granule formulation of hydrocortisone, Alkindi®, for treatment of paediatric adrenal insufficiency (Infacort development programme)

Porter, J., Withe, M., & Ross, R. J. (2018) · Expert Review of Endocrinology & Metabolism

Adrenal Hormones and DisordersPharmaceutical studies and practices

Cited by 26